Cushing Capital Partners’s Colgate-Palmolive CL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$319K Sell
3,482
-33
-0.9% -$2.89K 0.22% 84
2026
Q1
$300K Sell
3,515
-2,621
-43% -$234K 0.23% 86
2025
Q4
$485K Sell
6,136
-3,137
-34% -$246K 0.36% 65
2025
Q3
$741K Sell
9,273
-537
-5% -$45.8K 0.58% 56
2025
Q2
$892K Sell
9,810
-490
-5% -$44.7K 0.75% 46
2025
Q1
$965K Buy
+10,300
New +$922K 0.87% 45

Other funds holding CL

Cushing Capital Partners's CL Position: Q2 2026 in Review

Cushing Capital Partners reduced its Colgate-Palmolive (CL) stake by 0.94% in Q2 2026, selling an estimated $2.89K and leaving 3,482 shares worth $319K. The position accounts for 0.22% of the portfolio, ranked #84.

Cushing Capital Partners first reported a position in CL in Q1 2025 and has held it in 6 quarters since. The position peaked at $965K in Q1 2025. 2,020 funds tracked by Wall St. Rank hold CL as of Q2 2026.

  • Cushing Capital Partners held 3,482 shares of Colgate-Palmolive worth $319K as of Q2 2026.
  • Cushing Capital Partners sold 33 Colgate-Palmolive shares in Q2 2026, an estimated $2.89K.
  • Colgate-Palmolive made up 0.22% of Cushing Capital Partners's portfolio in Q2 2026, its #84 holding.
  • Cushing Capital Partners first reported a position in Colgate-Palmolive in Q1 2025 and has held it in 6 quarters since.
  • Cushing Capital Partners's Colgate-Palmolive position peaked at $965K in Q1 2025.
  • 2,020 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q2 2026.

Based on Cushing Capital Partners's 13F filing for Q2 2026, filed 29 Jul 2026.